HHLR ADVISORS LTD. 13D/13G Filings for Aligos Therapeutics, Inc. (ALGS)

HHLR ADVISORS LTD. 13D and 13G filings for Aligos Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-14
4:34 pm
Purchase
2024-09-3013GAligos Therapeutics, Inc.
ALGS
HHLR ADVISORS LTD.125,069
4.000%
125,069increase
(New Position)
Filing